High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.56

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart (2007) 1.75

Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER. J Heart Valve Dis (2012) 1.51

Should aspirin be continued in patients started on warfarin? J Gen Intern Med (2004) 0.86

Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation. Arq Bras Cardiol (2013) 0.82

Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis. Circ Cardiovasc Qual Outcomes (2016) 0.75

Antithrombotic therapy in patients with prosthetic heart valves. Libyan J Med (2009) 0.75

Optimal thromboprophylaxis following bioprosthetic aortic valve replacement: still a matter of debate? Interact Cardiovasc Thorac Surg (2012) 0.75

Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves. Clin Res Cardiol (2015) 0.75

Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group. BMJ (1994) 9.91

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation (1995) 8.19

Coronary plaque disruption. Circulation (1995) 8.04

Idiopathic dilated cardiomyopathy. N Engl J Med (1994) 7.74

The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62

New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J Cardiol (1995) 5.21

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol (2001) 4.89

Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation (1998) 4.63

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med (1993) 4.56

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43

Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation (2001) 4.24

Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med (1996) 3.97

Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation (2001) 3.94

Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (2001) 3.65

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol (2000) 3.54

The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53

Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr (1997) 3.53

Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol (2001) 3.39

Exercise tomographic thallium-201 imaging in patients with severe coronary artery disease and normal electrocardiograms. Ann Intern Med (1994) 3.38

Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation (1996) 3.34

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet (1993) 3.34

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J (2001) 3.34

Restrictive cardiomyopathy. N Engl J Med (1997) 3.29

Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation (1999) 3.25

Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation (1995) 3.23

ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol (2001) 3.23

The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16

Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation (1984) 3.15

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation (2001) 3.13

Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10

Race and sex differences in hip fracture incidence. Am J Public Health (1984) 3.07

Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation (2000) 3.02

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87

Calcific constrictive pericarditis: is it still with us? Ann Intern Med (2000) 2.81

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (2001) 2.79

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol (1990) 2.70

Secular trends in coronary atherosclerosis--analysis in patients with valvular regurgitation. N Engl J Med (1996) 2.68

Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin Proc (1994) 2.66

Surgical treatment of vascular rings: the Mayo Clinic experience. Mayo Clin Proc (1993) 2.63

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation (2001) 2.62

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest (1990) 2.55

Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med (1999) 2.54

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52

Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol (1999) 2.48

Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation (1996) 2.46

Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics (1989) 2.46

Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg (2005) 2.46

The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol (1981) 2.44

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41

The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol (1990) 2.40

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 2.37

ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart Association. J Am Coll Cardiol (1999) 2.35

Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res (2001) 2.35

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30

Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29

Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29

Five- to fifteen-year follow-up after Fontan operation. Circulation (1992) 2.26

Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation (2000) 2.26

Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25

Framingham Disability Study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am J Epidemiol (1985) 2.21

Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc (1995) 2.17

The significance of multiple, recurrent, and "complex" cardiac myxomas. J Thorac Cardiovasc Surg (1986) 2.12

Surgery for aortic regurgitation in women. Contrasting indications and outcomes compared with men. Circulation (1996) 2.11

Hyperbaric treatment of cerebral air embolism sustained during an open-heart surgical procedure. Mayo Clin Proc (1991) 2.11

Effect of Doppler echocardiography on utilization of hemodynamic cardiac catheterization in the preoperative evaluation of aortic stenosis. Mayo Clin Proc (1996) 2.09

Identification of multivessel coronary artery disease by exercise echocardiography. J Am Coll Cardiol (1994) 2.09

A randomized controlled trial of automated term composition. Proc AMIA Symp (1998) 2.08

Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol (1994) 2.08

Anomalous systemic venous connection. Surgical considerations. Mayo Clin Proc (1975) 2.06

Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation (1999) 2.06

Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc (2001) 2.06

Coronary restenosis: prospects for solution and new perspectives from a porcine model. Mayo Clin Proc (1993) 2.06

Diagnostic role of Doppler echocardiography in constrictive pericarditis. J Am Coll Cardiol (1994) 2.05

Low-dose aspirin and stroke. "It ain't necessarily so". Stroke (1992) 2.04

Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery. Anesthesiology (1993) 2.04

A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03

Ultrasound guidance improves the success rate of internal jugular vein cannulation. A prospective, randomized trial. Chest (1990) 2.02